Published in Pharm Res on June 01, 1992
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci (1996) 3.83
Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg (1997) 2.01
Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs. J Pharm Sci (1992) 1.45
The potential use of cyclodextrins in parenteral formulations. J Parenter Sci Technol (1989) 1.43
N-Halo derivatives VI: Microbiological and chemical evaluations of 3-chloro-2-oxazolidinones. J Pharm Sci (1976) 1.38
Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release (1999) 1.27
Properties of a new chloramine disinfectant and detoxicant. Poult Sci (1982) 1.23
Antimicrobial activity of N-chloramine compounds. J Pharm Sci (1980) 1.20
N-Halo derivatives V: Comparative antimicrobial activity of soft N-chloramine systems. J Pharm Sci (1976) 1.19
Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int J Pharm (2007) 1.09
Soft drugs. 1. Labile quaternary ammonium salts as soft antimicrobials. J Med Chem (1980) 0.99
Metabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonate. Pharm Res (1992) 0.97
Enhanced delivery of ganciclovir to the brain through the use of redox targeting. Antimicrob Agents Chemother (1994) 0.94
Octanol-water partition: searching for predictive models. Curr Med Chem (1998) 0.93
Photoelectron spectra, hydrolytic stability, and antimicrobial activity of N-chlorinated piperidines. J Pharm Sci (1974) 0.93
The use of human nasal in vitro cell systems during drug discovery and development. Toxicol In Vitro (2005) 0.92
Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. Pharmazie (2001) 0.92
Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. Curr Eye Res (1991) 0.92
Brain-targeted delivery of a leucine-enkephalin analogue by retrometabolic design. J Med Chem (1996) 0.90
Site-specific, sustained release of drugs to the brain. Science (1981) 0.89
Soft drugs--10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate. J Steroid Biochem Mol Biol (1991) 0.88
Structural studies of loteprednol etabonate and other analogs of prednisolone using NMR techniques. Steroids (1996) 0.87
Rational development of a soluble prodrug of a cytotoxic nucleoside: preparation and properties of arabinosyladenine 5'-formate. J Pharm Sci (1975) 0.87
Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms. Pharm Res (1998) 0.87
Targeting drugs to the brain by redox chemical delivery systems. Med Res Rev (2000) 0.87
Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs. Pharm Res (1991) 0.86
Problems of delivery of drugs to the brain. Pharmacol Ther (1982) 0.86
Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles. Int J Pharm (2006) 0.86
Soft drugs: principles and methods for the design of safe drugs. Med Res Rev (1984) 0.85
Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest Ophthalmol Vis Sci (1996) 0.85
Brain, blood, and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits. J Pharm Sci (1991) 0.85
The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems. Pharmazie (2002) 0.85
Design, synthesis, and pharmacokinetic evaluation of a chemical delivery system for drug targeting to lung tissue. J Pharm Sci (1996) 0.84
Physicochemical aspects of the enzymatic hydrolysis of carboxylic esters. Pharmazie (2002) 0.84
Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin. Pharm Res (1991) 0.83
Quantitative structure-metabolism relationships: steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters. J Med Chem (1999) 0.83
Transfer of phosphatidylcholine facilitated by a component of human plasma. Biochim Biophys Acta (1978) 0.83
Octanol-water partition of nonzwitterionic peptides: predictive power of a molecular size-based model. Proteins (1998) 0.83
A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine. J Forensic Sci (1988) 0.82
Effect of choline esters and oleic acid on the penetration of acyclovir, estradiol, hydrocortisone, nitroglycerin, retinoic acid and trifluorothymidine across hairless mouse skin in vitro. Acta Pharm Nord (1989) 0.82
Evaluation of a brain-targeting zidovudine chemical delivery system in dogs. Antimicrob Agents Chemother (1997) 0.82
Feasibility of localized immunosuppression: 1. Exploratory studies with glucocorticoids in a biohybrid device designed for cell transplantation. Pharmazie (2010) 0.81
Prediction of drug solubility in amphiphilic di-block copolymer micelles: the role of polymer-drug compatibility. Pharmazie (2007) 0.81
Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue. J Med Chem (1999) 0.81
Soft cannabinoid analogues as potential anti-glaucoma agents. Pharmazie (2000) 0.81
Soft drugs based on hydrocortisone: the inactive metabolite approach and its application to steroidal antiinflammatory agents. Pharm Res (1999) 0.81
Delivery of a quaternary pyridinium salt across the blood-brain barrier by its dihydropyridine derivative. Science (1975) 0.81
Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol. Acta Pharm Nord (1989) 0.81
Soft drugs. 12. Design, synthesis, and evaluation of soft bufuralol analogues. J Med Chem (2000) 0.81
Soft cannabinoid analogues as potential anti-glaucoma agents. Pharmazie (2002) 0.81
Improved delivery of acyclovir to the skin using a dihydrotrigonelline in equilibrium with trigonelline redox carrier. J Pharm Sci (1991) 0.81
Redox approaches to drug delivery to the central nervous system. NIDA Res Monogr (1992) 0.80
Targeting of drugs to the brain. Methods Enzymol (1985) 0.80
Stabilizing effect of tris(hydroxymethyl)aminomethane on N-nitrosoureas in aqueous solutions. J Pharm Sci (1992) 0.80
Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates. Pharmazie (2008) 0.80
Peroxidase-catalyzed S-oxygenation: mechanism of oxygen transfer for lactoperoxidase. Biochemistry (1991) 0.80
Dose-dependent brain delivery of zidovudine through the use of a zidovudine chemical delivery system. Pharm Res (1995) 0.80
Receptor binding studies of soft anticholinergic agents. AAPS PharmSci (2001) 0.80
17 beta-estradiol attenuates fimbrial lesion-induced decline of ChAT-immunoreactive neurons in the rat medial septum. Exp Neurol (1997) 0.80
Improved delivery through biological membranes. 1. Synthesis and properties of 1-methyl-1,6-dihydropyridine-2-carbaldoxime, a pro-drug of N-methylpyridinium-2-carbaldoxime chloride. J Med Chem (1976) 0.80
Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins. J Pharm Sci (1991) 0.80
Strategies to target kyotorphin analogues to the brain. J Med Chem (1998) 0.80
The effect of vehicle additives on the transdermal delivery of nitroglycerin. Pharm Res (1987) 0.80
Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. J Pharm Sci (1997) 0.79
Cardiovascular studies on different classes of soft drugs. Pharmazie (2000) 0.79
A simple, predictive, structure-based skin permeability model. J Pharm Pharmacol (2001) 0.79
Improved delivery through biological membranes. XXXL: Solubilization and stabilization of an estradiol chemical delivery system by modified beta-cyclodextrins. J Pharm Sci (1988) 0.79
Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins. J Parenter Sci Technol (1990) 0.79
Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution. Int J Pharm (1999) 0.79
Soft corticosteroids for local immunosuppression: exploring the possibility for the use of loteprednol etabonate for islet transplantation. Pharmazie (2008) 0.79
Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach. J Med Chem (1983) 0.79
Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Life Sci (1988) 0.79
Aqueous hydrocortisone mouthwash solution: clinical evaluation. Acta Odontol Scand (1998) 0.79
Ocular delivery of the beta-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue. J Med Chem (1995) 0.79
Short acting soft mydriatics. Curr Eye Res (1991) 0.79
High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats. Pharm Res (1988) 0.79
Targeted drug delivery to the central nervous system via phosphonate derivatives (anionic delivery system for testosterone). Pharmazie (2002) 0.79
Improved delivery through biological membranes. 4. Prodrugs of L-dopa. J Med Chem (1977) 0.78
Soft drugs. 21. Design and evaluation of soft analogs of propantheline. J Pharm Sci (1996) 0.78
Soft antibacterial agents. Curr Med Chem (2003) 0.78
Structure-based estimation of enzymatic hydrolysis rates and its application in computer-aided retrometabolic drug design. Pharmazie (2000) 0.78
Redox delivery system for brain-specific, sustained release of dopamine. Science (1983) 0.78
Preparation, characterization, and anesthetic properties of 2-hydroxypropyl-beta-cyclodextrin complexes of pregnanolone and pregnenolone in rat and mouse. J Pharm Sci (1995) 0.78
Dermal delivery of ETH-615, a zwitterionic drug. Drug Dev Ind Pharm (2000) 0.78
Characterization of self-assembling copolymers in aqueous solutions using Electron Paramagnetic Resonance and Fluorescence spectroscopy. J Control Release (2006) 0.78
Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant. Pharmazie (2010) 0.78
Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine. J Med Chem (1983) 0.78
A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits. Curr Eye Res (1992) 0.78